About: A comparative study of the laboratory features of COVID‐19 and other viral pneumonias in the recovery stage

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A comparative study of the laboratory features of COVID‐19 and other viral pneumonias in the recovery stage Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	A comparative study of the laboratory features of COVID‐19 and other viral pneumonias in the recovery stage
Creator	Yang, Ming Su, Yingying Tan, \| Cui, \| Dang, Liyun Sun, \| Wang, Hongrui Zhao, Guolian Lijuan Zhao, \|
source	Medline; PMC
abstract	BACKGROUND: Clinical recovery does not mean full recovery. It is necessary to explore the aftereffects of COVID‐19 in patients and compare the laboratory features of COVID‐19 and other viral pneumonias in the recovery stages. METHODS: Forty‐seven cases of COVID‐19 and 45 cases of other viral pneumonias (control) were included in this study. The laboratory parameters were compared between COVID‐19 and control patients as well as severe and moderate COVID‐19 patients from the clinical recovery stage to the 4 weeks postdischarge recovery stage. RESULTS: A higher RDW‐CV level and neutrophil percentage and lower levels of total proteins, lymphocytes, eosinophils, and MCH were found in COVID‐19 patients compared with those in controls from the clinical recovery to the postdischarge recovery stages. Further analysis showed that decreases in lymphocytes, total proteins, and SOD and elevations in neutrophils, FDP, CRP, and ESR were more common in severe than moderate cases of COVID‐19 during hospitalization; however, differences in these indicators, except total proteins, were not observed in the postdischarge recovery stages. Additionally, only 76.9% of COVID‐19 patients were positive for IgG antibodies against SARS‐CoV‐2 in the convalescence stage, and one patient that was negative for specific IgG was reinfected. CONCLUSIONS: This study demonstrated that patients recovering from COVID‐19 might need better care than that patients with other viral pneumonias due to the possibility of having poor immunity and nutritional conditions. These findings provide new insights to improve the understanding of COVID‐19 and improve care for patients affected by these kinds of pandemics in the future.
has issue date	2020-07-21(xsd:dateTime)
bibo:doi	10.1002/jcla.23483
bibo:pmid	32696465
has license	cc-by
sha1sum (hex)	1016fc58593492ea195614b6e3ed8d1be960973a
schema:url	https://doi.org/10.1002/jcla.23483
resource representing a document's title	A comparative study of the laboratory features of COVID‐19 and other viral pneumonias in the recovery stage
has PubMed Central identifier	PMC7404602
has PubMed identifier	32696465
schema:publication	J Clin Lab Anal
resource representing a document's body	covid:1016fc58593492ea195614b6e3ed8d1be960973a#body_text
is schema:about of	named entity 'BACKGROUND' named entity 'recovery' named entity 'COVID-19' named entity 'aftereffects' named entity 'Clinical' named entity 'laboratory' named entity 'COVID-19' named entity 'red blood cell distribution width' named entity 'statistically significant' named entity 'rRT-PCR' named entity 'ground-glass opacities' named entity 'degradation products' named entity 'COVID' named entity 'lymphopenia' named entity 'C-reactive protein' named entity 'COVID' named entity 'acute respiratory distress syndrome' named entity 'COVID-19' named entity 'neutrophils' named entity 'pandemics' named entity 'etiological agent' named entity 'COVID-19' named entity 'COVID-19' named entity 'rRT-PCR' named entity 'coronavirus' named entity 'COVID' named entity 'computed tomography' named entity 'viral RNA' named entity 'fully normal' named entity 'pathogens' named entity 'severe acute respiratory syndrome coronavirus' named entity 'chest CT' named entity 'cough' named entity 'nucleic acid test' named entity 'degradation products' named entity 'COVID' named entity 'control patients' named entity 'COVID-19' named entity 'virus' named entity 'gastrointestinal symptoms' named entity '2.0' named entity 'IgM antibodies' named entity 'fatigue' named entity 'significant difference' named entity 'COVID-19' named entity 'IgM' named entity 'chronic illnesses' named entity 'reverse transcription-polymerase chain reaction' named entity '11.25' named entity 'SPSS' named entity 'Johns Hopkins University' named entity 'Ming Yang' named entity 'Bayer' named entity 'body temperature' named entity 'SARS-CoV' named entity 'COVID-19' named entity 'Mann-Whitney' named entity 'cytokine storms' named entity 'diarrhea' named entity 'COVID-19' named entity 'Werfen' named entity 'superoxide dismutase' named entity 'COVID' named entity 'IgG antibodies' named entity 'genus' named entity 'COVID' named entity 'COVID-19' named entity 'biochemical' named entity 'GraphPad Prism' named entity 'high fever' named entity 'genome' named entity 'nucleic acid detection' named entity 'expectoration'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software